ID23435A - Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns - Google Patents

Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns

Info

Publication number
ID23435A
ID23435A IDW990935D ID990935D ID23435A ID 23435 A ID23435 A ID 23435A ID W990935 D IDW990935 D ID W990935D ID 990935 D ID990935 D ID 990935D ID 23435 A ID23435 A ID 23435A
Authority
ID
Indonesia
Prior art keywords
neurodegeratives
attropisomers
heteroaril
quinazolinone
cns
Prior art date
Application number
IDW990935D
Other languages
English (en)
Inventor
Bertrand Leo Chenard
Keith Michael De Vries
Willard Mckowan Welch Jr
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID23435A publication Critical patent/ID23435A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW990935D 1997-02-28 1998-02-06 Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns ID23435A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3854097P 1997-02-28 1997-02-28

Publications (1)

Publication Number Publication Date
ID23435A true ID23435A (id) 2000-04-20

Family

ID=21900535

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990935D ID23435A (id) 1997-02-28 1998-02-06 Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns

Country Status (40)

Country Link
US (1) US6380204B1 (id)
EP (1) EP0964860B1 (id)
JP (1) JP3299990B2 (id)
KR (1) KR20000075812A (id)
CN (1) CN1248254A (id)
AP (1) AP9801202A0 (id)
AR (1) AR011886A1 (id)
AT (1) ATE264854T1 (id)
AU (1) AU732448B2 (id)
BG (1) BG103687A (id)
BR (1) BR9807807A (id)
CA (1) CA2282279C (id)
CO (1) CO4950615A1 (id)
DE (1) DE69823339T2 (id)
DK (1) DK0964860T3 (id)
DZ (1) DZ2438A1 (id)
EA (1) EA001961B1 (id)
ES (1) ES2218801T3 (id)
GT (1) GT199800039A (id)
HN (1) HN1998000028A (id)
HR (1) HRP980108B1 (id)
HU (1) HUP0000935A3 (id)
ID (1) ID23435A (id)
IL (1) IL130897A0 (id)
IS (1) IS5141A (id)
MA (1) MA24485A1 (id)
NO (1) NO994178D0 (id)
NZ (1) NZ336627A (id)
OA (1) OA11088A (id)
PA (1) PA8446901A1 (id)
PE (1) PE57999A1 (id)
PL (1) PL335307A1 (id)
PT (1) PT964860E (id)
SK (1) SK113199A3 (id)
TN (1) TNSN98034A1 (id)
TR (1) TR199902094T2 (id)
TW (1) TW530055B (id)
UA (1) UA58536C2 (id)
WO (1) WO1998038187A1 (id)
ZA (1) ZA981665B (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323208B1 (en) * 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
JPH11279158A (ja) * 1998-02-09 1999-10-12 Pfizer Prod Inc キナゾリン―４―オン誘導体の製造方法
US6890930B1 (en) * 1999-09-28 2005-05-10 3-Dimensional Pharmaceuticals, Inc. Quinazolinones
EP1660486A4 (en) * 2003-08-08 2006-12-13 Ulysses Pharmaceutical Product HALOGENATED CHINAZOLINYL NITROFURANES AS ANTIBACTERIAL AGENTS
US20080146562A1 (en) * 2003-08-08 2008-06-19 Ulysses Pharmaceutical Products Inc., Halogenated quinazolinyl nitrofurans as antibacterial agents
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7893260B2 (en) 2005-11-04 2011-02-22 Hydra Biosciences, Inc. Substituted quinazolin-4-one compounds for antagonizing TRPV3 function
WO2008041118A2 (en) * 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
WO2008140750A1 (en) * 2007-05-10 2008-11-20 Hydra Biosciences Inc. Compounds for modulating trpv3 function
CA2756347A1 (en) * 2009-03-24 2010-09-30 Gilead Calistoga Llc Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
ES2739973T3 (es) 2009-05-29 2020-02-05 Merck Sharp & Dohme Inhibidores de PDE10 radiomarcados
WO2013105985A1 (en) 2011-02-28 2013-07-18 Philadelphia Health & Education Corporation Small molecule inhibitors of rad51 recombinase and methods thereof
EP4096661B1 (en) 2020-01-29 2025-04-02 Kamari Pharma Ltd. Compounds and compositions for use in treating skin disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1298603A (en) 1970-04-06 1972-12-06 Karamchand Premchand Private Quinazolinone derivatives
US4183931A (en) * 1977-09-08 1980-01-15 Research Corporation 2-Ketoalkyl-4(3H)-quinazolinones
WO1992013535A1 (en) 1991-02-06 1992-08-20 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
DE69716810T2 (de) * 1996-05-15 2003-02-27 Pfizer Inc., New York 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
KR100375155B1 (ko) * 1996-05-15 2003-08-19 화이자 인코포레이티드 신규한2,3-이치환된-4(3에이치)-퀴나졸리논

Also Published As

Publication number Publication date
UA58536C2 (uk) 2003-08-15
JP2000509732A (ja) 2000-08-02
NO994178L (no) 1999-08-27
CO4950615A1 (es) 2000-09-01
EP0964860A1 (en) 1999-12-22
CN1248254A (zh) 2000-03-22
WO1998038187A1 (en) 1998-09-03
AR011886A1 (es) 2000-09-13
HUP0000935A2 (hu) 2001-04-28
CA2282279C (en) 2004-11-02
DE69823339D1 (de) 2004-05-27
SK113199A3 (en) 2001-10-08
OA11088A (en) 2002-03-15
ES2218801T3 (es) 2004-11-16
IS5141A (is) 1999-07-30
IL130897A0 (en) 2001-01-28
PA8446901A1 (es) 2000-05-24
DZ2438A1 (fr) 2003-01-11
US6380204B1 (en) 2002-04-30
GT199800039A (es) 1999-08-13
PL335307A1 (en) 2000-04-10
MA24485A1 (fr) 1998-10-01
ZA981665B (en) 1999-08-17
AP9801202A0 (en) 1999-08-26
AU732448B2 (en) 2001-04-26
PT964860E (pt) 2004-07-30
TW530055B (en) 2003-05-01
BG103687A (en) 2000-06-30
CA2282279A1 (en) 1998-09-03
TNSN98034A1 (fr) 2005-03-15
NZ336627A (en) 2000-12-22
EA001961B1 (ru) 2001-10-22
ATE264854T1 (de) 2004-05-15
HUP0000935A3 (en) 2002-04-29
DK0964860T3 (da) 2004-07-26
HN1998000028A (es) 1999-02-09
NO994178D0 (no) 1999-08-27
EA199900689A1 (ru) 2000-02-28
PE57999A1 (es) 1999-06-21
JP3299990B2 (ja) 2002-07-08
HRP980108A2 (en) 1998-12-31
AU5775998A (en) 1998-09-18
TR199902094T2 (xx) 1999-12-21
DE69823339T2 (de) 2005-05-12
KR20000075812A (ko) 2000-12-26
BR9807807A (pt) 2000-02-22
EP0964860B1 (en) 2004-04-21
HRP980108B1 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
ID23435A (id) Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns
IL130900A0 (en) Atropisomers of 3-aryl-4(3H)- quinazolinones and their use as ampa-receptor antagonsts
ID24202A (id) Multi-fase agregat yang terdiri dari karbon dan preparasinya
ID22389A (id) Komposisi dan metode untuk menurunkan hipertensi okuler
DE69838386D1 (de) Beleuchtungssystem und dessen anwendung
ID25504A (id) Pencegahan dan pengobatan penyakit amiloidogenik
FI973163L (fi) Pidätyskyvyttömyyden hoitaminen käyttämällä (S)-oksibutyniiniä ja (S)-desetyylioksibutyniiniä
IT1283046B1 (it) Procedimento per riconoscere mancate combustioni
DE69634822D1 (de) Amid-verbindungen und ihre anwendung
AU7165798A (en) Use of genistein and related compounds to treat certain sex hormone related conditions
ID20973A (id) Senyawa-senyawa polietilenimina berat molekul rendah yang dapat ditoleransi secara biologi
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
IT1283827B1 (it) Procedimento per riconoscere mancate combustioni
DE69836209D1 (de) Vorbeugung und behandlunhg des hepatozellulären krebses
ID22449A (id) Campuran zat dapat yang didasarkan pada sulfonil dan adjuvan
ID26955A (id) Komposisi farmasi homogen yang terdiri dari abacavir, lamivudin dan zidovudin
ID28277A (id) Komposisi-komposisi yang terdiri dari analog-analog gaba dan kaffein
IT1290561B1 (it) Procedimento per riconoscere mancate combustioni
DE59912433D1 (de) Vorverzerrung zur verringerung von intersymbolinterferenz sowie mehrfachzugriffsinterferenz
IT1282569B1 (it) Procedimento per riconoscere mancate combustioni
EP0998578A4 (en) SEL-10 AND ITS USES
DE69605010D1 (de) Trifluormethansulfinanilidverbindung und ihre Anwendung
ID22685A (id) Penghilangan 6-aminokapronitril dari campuran yang terdiri dari 6-aminokapronitril dan imina
ID22388A (id) Formulasi dan bentuk polimorfik dari desferioksamin dan pembuatannya
EP0934063A4 (en) USE OF SIALIDASE ANTIBODIES AS ANTI-INFECTIOUS AND ANTI-INFLAMMATORY AGENTS